International Biotechnology Trust’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.86M | Buy |
+63,000
| New | +$2.86M | 0.96% | 32 |
|
|
2023
Q2 | – | Sell |
-34,200
| Closed | -$1.55M | – | 68 |
|
|
2023
Q1 | $1.55M | Hold |
34,200
| – | – | 0.43% | 46 |
|
|
2022
Q4 | $1.39M | Hold |
34,200
| – | – | 0.43% | 42 |
|
|
2022
Q3 | $2.24M | Buy |
34,200
+32,122
| +1,546% | +$2.1M | 0.72% | 40 |
|
|
2022
Q2 | $34.2K | Buy |
+2,078
| New | +$34.2K | 0.36% | 52 |
|
|
2022
Q1 | – | Sell |
-108,200
| Closed | -$8.19M | – | 74 |
|
|
2021
Q4 | $8.19M | Buy |
+108,200
| New | +$8.19M | 1.83% | 21 |
|
|
2021
Q2 | – | Sell |
-22,000
| Closed | -$2.68M | – | 68 |
|
|
2021
Q1 | $2.68M | Hold |
22,000
| – | – | 0.71% | 29 |
|
|
2020
Q4 | $3.37M | Hold |
22,000
| – | – | 0.92% | 24 |
|
|
2020
Q3 | $1.84M | Hold |
22,000
| – | – | 0.59% | 30 |
|
|
2020
Q2 | $1.65M | Hold |
22,000
| – | – | 0.55% | 30 |
|
|
2020
Q1 | $930K | Hold |
22,000
| – | – | 0.42% | 36 |
|
|
2019
Q4 | $1.34M | Buy |
+22,000
| New | +$1.34M | 0.48% | 44 |
|